XML 90 R79.htm IDEA: XBRL DOCUMENT v3.25.3
Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Earnings Per Share [Abstract]        
Loss before preferred dividends and accretion of Series A Preferred Stock including excise tax $ (20,864) $ (23,137) $ (105,379) $ (38,821)
Dividends and accretion of Series A Preferred Stock including excise tax (6,066) (8,094) (44,891) (24,018)
Net loss attributable to common shareholders of Evolent Health, Inc. - basic (26,930) (31,231) (150,270) (62,839)
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted $ (26,930) $ (31,231) $ (150,270) $ (62,839)
Weighted-average common shares outstanding - basic (in shares) 114,066 114,862 115,083 114,565
Weighted-average common shares outstanding - diluted (in shares) 114,066 114,862 115,083 114,565
Basic and diluted        
Basic (in dollars per share) $ (0.24) $ (0.27) $ (1.31) $ (0.55)
Diluted (in dollars per share) $ (0.24) $ (0.27) $ (1.31) $ (0.55)